133 related articles for article (PubMed ID: 34158422)
1. Bisphosphonate Use Does Not Impact Survival in Patients with Pancreatic Cancer: A Propensity Score Matching Analysis.
Zylberberg HM; Rustgi SD; Yang A; Aronson A; Kessel E; Amin S; Lucas AL
Gut Liver; 2021 Sep; 15(5):782-790. PubMed ID: 34158422
[TBL] [Abstract][Full Text] [Related]
2. Metformin Improves Survival in Patients with Pancreatic Ductal Adenocarcinoma and Pre-Existing Diabetes: A Propensity Score Analysis.
Amin S; Mhango G; Lin J; Aronson A; Wisnivesky J; Boffetta P; Lucas AL
Am J Gastroenterol; 2016 Sep; 111(9):1350-7. PubMed ID: 27430290
[TBL] [Abstract][Full Text] [Related]
3. The association of statin use after cancer diagnosis with survival in pancreatic cancer patients: a SEER-medicare analysis.
Jeon CY; Pandol SJ; Wu B; Cook-Wiens G; Gottlieb RA; Merz CN; Goodman MT
PLoS One; 2015; 10(4):e0121783. PubMed ID: 25830309
[TBL] [Abstract][Full Text] [Related]
4. Beta-blockers have no impact on survival in pancreatic ductal adenocarcinoma prior to cancer diagnosis.
Yang A; Zylberberg HM; Rustgi SD; Amin SP; Bar-Mashiah A; Boffetta P; Lucas AL
Sci Rep; 2021 Jan; 11(1):1038. PubMed ID: 33441781
[TBL] [Abstract][Full Text] [Related]
5. Epidemiologic Analysis Along the Mevalonate Pathway Reveals Improved Cancer Survival in Patients Who Receive Statins Alone and in Combination With Bisphosphonates.
El-Refai SM; Brown JD; Arnold SM; Black EP; Leggas M; Talbert JC
JCO Clin Cancer Inform; 2017 Nov; 1():1-12. PubMed ID: 30657380
[TBL] [Abstract][Full Text] [Related]
6. Whether early stage pancreatic ductal adenocarcinoma patients could benefit from the post-operation chemotherapy regimens: a SEER-based propensity score matching study.
Shi J; Li X; Wu Y
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Jun; 50(3):375-382. PubMed ID: 34402250
[TBL] [Abstract][Full Text] [Related]
7. Differential and Joint Effects of Metformin and Statins on Overall Survival of Elderly Patients with Pancreatic Adenocarcinoma: A Large Population-Based Study.
E JY; Lu SE; Lin Y; Graber JM; Rotter D; Zhang L; Petersen GM; Demissie K; Lu-Yao G; Tan XL
Cancer Epidemiol Biomarkers Prev; 2017 Aug; 26(8):1225-1232. PubMed ID: 28619830
[No Abstract] [Full Text] [Related]
8. The effect of statins on survival in patients with stage IV lung cancer.
Lin JJ; Ezer N; Sigel K; Mhango G; Wisnivesky JP
Lung Cancer; 2016 Sep; 99():137-42. PubMed ID: 27565929
[TBL] [Abstract][Full Text] [Related]
9. Opioid Prescription Is Associated With Increased Survival in Older Adult Patients With Pancreatic Cancer in the United States: A Propensity Score Analysis.
Zylberberg HM; Woodrell C; Rustgi SD; Aronson A; Kessel E; Amin S; Lucas AL
JCO Oncol Pract; 2022 May; 18(5):e659-e668. PubMed ID: 34990289
[TBL] [Abstract][Full Text] [Related]
10. Albumin-to-alkaline phosphatase ratio serves as a prognostic indicator in unresectable pancreatic ductal adenocarcinoma: a propensity score matching analysis.
Zhang K; Dong S; Jing YH; Gao HF; Chen LY; Hua YQ; Chen H; Chen Z
BMC Cancer; 2020 Jun; 20(1):541. PubMed ID: 32517802
[TBL] [Abstract][Full Text] [Related]
11. Preoperative radiotherapy improves overall survival of pT4 pancreatic ductal adenocarcinoma patients after surgical resection.
Xu Y; Zhang Y; Wu Z; Wang D; Wu W; Kuang T; Lou W
Jpn J Clin Oncol; 2020 Jun; 50(6):679-687. PubMed ID: 32372083
[TBL] [Abstract][Full Text] [Related]
12. Celiac Plexus Neurolysis Is Associated With Decreased Survival in Patients With Pancreatic Cancer: A Propensity Score Analysis.
Zylberberg HM; Nagula S; Rustgi SD; Aronson A; Kessel E; Kumta NA; DiMaio CJ; Lucas AL
Pancreas; 2022 Feb; 51(2):153-158. PubMed ID: 35404890
[TBL] [Abstract][Full Text] [Related]
13. Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis.
Wang D; Liu C; Zhou Y; Yan T; Li C; Yang Q; Xu Y; Zhao L; Pei Q; Tan F; Güngör C; Li Y
Radiat Oncol; 2020 May; 15(1):107. PubMed ID: 32404114
[TBL] [Abstract][Full Text] [Related]
14. Survival in older women with early stage breast cancer receiving low-dose bisphosphonates or denosumab.
Suarez-Almazor ME; Herrera R; Lei X; Chavez-MacGregor M; Zhao H; Giordano SH
Cancer; 2020 Sep; 126(17):3929-3938. PubMed ID: 32573777
[TBL] [Abstract][Full Text] [Related]
15. Early-onset pancreatic cancer: a population-based study using the SEER registry.
Ansari D; Althini C; Ohlsson H; Andersson R
Langenbecks Arch Surg; 2019 Aug; 404(5):565-571. PubMed ID: 31377855
[TBL] [Abstract][Full Text] [Related]
16. Prior history of acute pancreatitis predicts poor survival in patients with resectable pancreatic ductal adenocarcinoma.
Gong Y; Fan Z; Luo G; Huang Q; Qian Y; Cheng H; Jin K; Ni Q; Yu X; Liu C
Pancreatology; 2020 Jun; 20(4):716-721. PubMed ID: 32249060
[TBL] [Abstract][Full Text] [Related]
17. Impact of statin use on survival in patients undergoing resection for early-stage pancreatic cancer.
Wu BU; Chang J; Jeon CY; Pandol SJ; Huang B; Ngor EW; Difronzo AL; Cooper RM
Am J Gastroenterol; 2015 Aug; 110(8):1233-9. PubMed ID: 26195180
[TBL] [Abstract][Full Text] [Related]
18. Tumor location as an indicator of survival in T1 resectable pancreatic ductal adenocarcinoma: a propensity score-matched analysis.
Meng Z; Cao M; Zhang Y; Liu Z; Wu S; Wu H
BMC Gastroenterol; 2019 Apr; 19(1):59. PubMed ID: 31014264
[TBL] [Abstract][Full Text] [Related]
19. Impact of Immunotherapy after Resection of Pancreatic Cancer.
Tran TB; Maker VK; Maker AV
J Am Coll Surg; 2019 Jul; 229(1):19-27.e1. PubMed ID: 30742911
[TBL] [Abstract][Full Text] [Related]
20. Influence of Statins and Cholesterol on Mortality Among Patients With Pancreatic Cancer.
Huang BZ; Chang JI; Li E; Xiang AH; Wu BU
J Natl Cancer Inst; 2017 May; 109(5):. PubMed ID: 28040693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
